Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoptarelin doxorubicin vs doxorubicin in endometrial cancer
NCT01767155Phase 3Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Apr 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 22
01
Overview
A Phase 3 trial of zoptarelin doxorubicin in endometrial cancer (EC), sponsored by COSCIENS Biopharma Inc.. Started Apr 2013; status: completed.
02
Drugs
zoptarelin doxorubicin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01767155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01767155.